Renalytix AI plc Gains 38.1%
Tue, Oct 25, 2022 at 07:33 PM
Renalytix AI plc (RNLX:NASDAQ) soared at $1.45, representing a gain of 38.1%. On Tue, Oct 25, 2022, RNLX:NASDAQ touched a New 2-Week High of $1.45. The stock got featured on our News Catalysts scanner on Mon, Oct 24, 2022 at 08:16 AM in the 'EARNINGS' category. From Tue, Oct 11, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days
About Renalytix AI plc (RNLX:NASDAQ)
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally.
Top 10 Gainers:
- Taysha Gene Therapies Inc. (TSHA:NASDAQ), 97.35%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 89.64%
- Renalytix AI plc (RNLX:NASDAQ), 38.1%
- Medpace Holdings, Inc. (MEDP:NASDAQ), 37.71%
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 37.47%
- Argo Blockchain plc (ARBK:NASDAQ), 36.23%
- SpringBig Holdings Inc. (SBIG:NASDAQ), 31.43%
- Weber Inc. Class A (WEBR:NYSE), 30.42%
- Nutex Health Inc. (NUTX:NASDAQ), 29.51%
- Canopy Growth Corporation (CGC:NASDAQ), 27.07%